Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Total 13F shares
-
96,771,026
-
Share change
-
-26,096,692
-
Total reported value
-
$86,789,528
-
Put/Call ratio
-
63%
-
Price per share
-
$0.90
-
Number of holders
-
140
-
Value change
-
-$22,993,945
-
Number of buys
-
53
-
Number of sells
-
76
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2023
As of 30 Jun 2023,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,771,026 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., CITADEL ADVISORS LLC, PNC Financial Services Group, Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JUPITER ASSET MANAGEMENT LTD, and Cubist Systematic Strategies, LLC.
This page lists
141
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.